Fintel reports that on April 4, 2025, Redburn Atlantic downgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Buy to ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Labcorp Holdings (NYSE:LH) with a Buy ...

Redburn Atlantic downgraded Qiagen (QGEN) to Neutral from Buy with a price target of EUR 41, down from EUR 47. The firm reduced the company’s ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Redburn Atlantic started coverage on shares of Laboratory Co. of America (NYSE:LH – Free Report) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating ...

Redburn Atlantic analyst Joshua Smith initiated coverage of Ionis Pharmaceuticals (IONS) with a Neutral rating and $39 price target Ionis is a ...

Reddit has grown quickly since going public last year, but some analysts warn that its growth could be dependent on Google ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of Alnylam Pharmaceuticals (BMV:ALNY) with a Buy recommendation. Capital World Investors holds 16,601K shares ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of Ionis Pharmaceuticals (BMV:IONS) with a Neutral recommendation. T. Rowe Price Investment Management holds 14,169K ...